Stephens Reaffirms Overweight Rating for Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA)‘s stock had its “overweight” rating restated by Stephens in a note issued to investors on Thursday,Benzinga reports. They currently have a $26.00 price target on the stock. Stephens’ price objective points to a potential upside of 30.26% from the stock’s previous close.

Several other brokerages also recently commented on PRVA. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. KeyCorp initiated coverage on Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Truist Financial raised their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. Finally, Barclays increased their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and an average price target of $24.88.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $19.96 on Thursday. Privia Health Group has a one year low of $15.92 and a one year high of $23.78. The stock has a market cap of $2.40 billion, a price-to-earnings ratio of 199.62, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83. The stock has a 50 day moving average price of $20.71 and a 200-day moving average price of $19.30.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Canada Pension Plan Investment Board bought a new position in shares of Privia Health Group in the 2nd quarter worth $26,000. GAMMA Investing LLC grew its stake in Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the last quarter. Signaturefd LLC raised its holdings in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares in the last quarter. Quarry LP lifted its position in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares during the last quarter. Finally, KBC Group NV boosted its holdings in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.